Transforming Discovery into Opportunity

NeuroCDRD, a new drug development platform jointly led by CDRD, the Montreal Neurological Institute and Hospital at McGill University (MNI), & Merck aims to accelerate the development of new treatments for ALS and Parkinson’s disease.

More details…

Join CDRD & top cancer researchers and clinicians from across Canada to learn about novel platforms in cancer immunotherapy research, implications for the discovery of therapeutic candidates, lessons learned, and to discuss how novel platforms may advance cancer immunotherapy R&D in Canada.

Details and agenda…

We enjoyed meeting everyone at the BC Tech Summit!

Thanks to Jason Crawford, our VP of Scientific Operations for participating in the Innovating Healthcare panel along with our partners Zymeworks, Stemcell Technologies, Innovation Boulevard & UBC

CDRD is proud to a founding partner of the Regenerative Medicine Alliance of Canada along with other founding members: CCRM; CellCan; Medicine by Design; Ontario Institute for Regenerative Medicine; ThéCell; Canadian Stem Cell Foundation, and Stem Cell Network.

More details here…

Partners including CDRD, STEMCELL Technologies, Stem Cell Network, CCRM and more are hosting the BC Regenerative Medicine Research Symposium on May 10th.

Registration now open. More details…

Join us at the 2nd Personalized Medicine Summit 2017, June 11-13 2017 at the University of British Columbia (UBC).

Details here

CDRD is a partner in one of 16 new collaborative research projects announced by BioCanRx. These projects are aimed at finding improved treatment options and outcomes for cancer patients and  developing clinical Chimeric Antigen Receptor modified T cell (CAR-T) manufacturing capabilities in Canada.

Find out how…

CDRD Expands Global Industry Partnerships with Addition of AstraZeneca!

This private/public partnership will continue to support Canadian health research projects by advancing promising research from the university labs through independent testing and validation and towards clinical trials and commercialization.

Read more…

Health sciences researchers, entrepreneurs, and companies alike have the opportunity to collaborate with CDRD and thereby access its full suite of expertise, infrastructure, and broad partnerships and networks.

Find out how CDRD supports Canadian Small/Medium Enterprises (SMEs)……

CDRD BY THE NUMBERS:

  • Over 1,100 early-stage technologies evaluated for commercial potential
  • Over 200 projects on 134 distinct technologies
  • 56 technologies advanced toward commercialization and/or commercialized
  • 7 spin-off companies launched
  • 14 technologies out-licensed

What is CDRD?

Headquartered in Vancouver, British Columbia, The Centre for Drug Research and Development (CDRD) is Canada’s national drug development and commercialization engine.

We work in partnership with academia, industry, government and foundations, to provide the specialized expertise and infrastructure to identify and de-risk promising discoveries generated by health-related research, and transform them into commercially viable investment opportunities for the private sector – and ultimately into innovative new therapies for patients.

In doing so, CDRD is actively growing our national health sciences industry into a wholly-optimized generator of economic prosperity for the country.

Since 2008, Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).

Latest from the Blog

CDRD part of $1.5 million project with MNI to advance new treatments for Parkinson’s Disease

Microdermics Wins BCIC-New Ventures Competition & $10,000 in Commercial Support from CDRD

+ VISIT THE BLOG

Latest from Twitter


+ FOLLOW US ON TWITTER



A Shared Vision










  • Industry
  • Academia
  • Government

Sign up to our newsletter

Receive CDRD's e-newsletter, The CDRD Pipeline and other e-communications for regular updates on all our news and activities.



© Copyright 2017 CDRD. All rights reserved.

>